Skip to content

ALLO ALLOGENE THERAPEUTICS INC

Follow

COM (common), issuer CIK 1737287

204 managers (209 13F filers) reported a position in ALLO shares at 2026-06-30, 312,657,330 shares in all. 32 filers opened a position and 30 filers sold out during the quarter.

Managers
204
13F filers
209
New
32
Added
99
Reduced
49
Sold out
30
Shares held by filers
312,657,330

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q2 2026

Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Clearstead Advisors, LLC34$71<0.01%new13F-HRTimeline
ARCADIA INVESTMENT ADVISORS LLC20$42<0.01%013F-HRTimeline
Avion Wealth440$00%013F-HRTimelineValue filed as zero, left out of ratios.
Covestor Ltd121$00%+8513F-HRTimelineValue filed as zero, left out of ratios.

Events

  • TPG GP A, LLC and 2 other reporting persons reported 0 ALLO shares, 0% of the class, as of 2026-09-28, in a 13D/A filed 2026-09-30. 0001999371-26-021654

    Accepted , ingested